Mi‐Jin Sohn

854 citations
26 papers · 734 indexed · h-index 15
Topics
Microbial Natural Products and Biosynthesis (11 papers)Antimicrobial Peptides and Activities (8 papers)Antimicrobial agents and applications (7 papers)

In The Last Decade

Mi‐Jin Sohn

26 papers receiving 724 citations

Peers

Mi‐Jin Sohn
Comparison fields: 5 of 89
  • Molecular Biology 311
  • Pharmacology 162
  • Organic Chemistry 152
  • Cellular and Molecular Neuroscience 134
  • Plant Science 79
Replace Sako Mirzaie with:
Sako Mirzaie Iran
Libin Ye United States
Stanton F. McHardy United States
Varomyalin Tipmanee Thailand
Olga S. Ostroumova Russia
Ravi S. Lankalapalli India
Izabela Dobrzyńska Poland
Giovanni Grazioso Italy
Márcia Machado Marinho Brazil
Qing Lu China
Mi‐Jin Sohn relative to Sako Mirzaie Iran Sako Mirzaie's profile →
Citations per field
00.5×4.2×
Sako Mirzaie · 1×
Citations per year

Countries citing papers authored by Mi‐Jin Sohn

Since Specialization
Citations

This map shows the geographic impact of Mi‐Jin Sohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi‐Jin Sohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi‐Jin Sohn more than expected).

Fields of papers citing papers by Mi‐Jin Sohn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mi‐Jin Sohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi‐Jin Sohn. The network helps show where Mi‐Jin Sohn may publish in the future.

Co-authorship network of co-authors of Mi‐Jin Sohn

This figure shows the co-authorship network connecting the top 25 collaborators of Mi‐Jin Sohn. A scholar is included among the top collaborators of Mi‐Jin Sohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mi‐Jin Sohn. Mi‐Jin Sohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 2
3 151
4 43
5 28
6 42
7 52
8 9
9 26
10 5
11 29
12 6
13 31
14 20
15 12
16 11
17 36
18 45
19 11
20 36

About Mi‐Jin Sohn

Mi‐Jin Sohn is a scholar working on Microbiology, Pharmacology and Bioengineering, having authored 26 papers that have together received 734 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (11 papers), Antimicrobial Peptides and Activities (8 papers) and Antimicrobial agents and applications (7 papers). The work is most often cited by research in Pharmacology (162 citations), Molecular Medicine (39 citations) and Cellular and Molecular Neuroscience (134 citations). Mi‐Jin Sohn has collaborated with scholars based in South Korea, Japan and United States. Frequent co-authors include Won‐Gon Kim, Chang‐Ji Zheng, Won-Gon Kim, Sangku Lee, Chang Ji Zheng, Hiroyuki Koshino, Joongku Lee, Kwang‐Soo Kim, Chun‐Hyung Kim and Baek‐Soo Han. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Analytical Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026